Elsevier

Neuroscience Letters

Volume 174, Issue 1, 6 June 1994, Pages 21-25
Neuroscience Letters

Localization of the antinociceptive and antianalgesic effects of neurotensin within the rostral ventromedial medulla

https://doi.org/10.1016/0304-3940(94)90109-0Get rights and content

Abstract

Triple microinjections of neurotensin (10 nmol each), which occupied a large volume of tissue within the nucleus reticularis gigantocellularis (Gi), produced an inhibition of the tail-flick reflex in awake rats. This effect was less than that previously observed by a single injection (10 nmol) into the nucleus raphe magnus (RMg) (see ref. [25]). Bilateral injections of neurotensin (10 nmol each) into the nucleus reticularis paragigantocellularis lateralis (LPGi) had no effect. The neurotensin antagonist [d-Trp11]-neurotensin (3 pmol) was previously found to enhance morphine, but not β-endorphin antinociception from the periaqueductal gray (PAG) when injected into the RMg. A similar enhancement of morphine, but not β-endorphin antinociception from the PAG was observed in the current study by [d-Trp11]-neurotensin injections into the bilateral LPGi, bilateral Gi, or medial Gi. These data suggest that neurotensinergic projections from the PAG function in an antianalgesic manner throughout the RVM during morphine, but not β-endorphin antinociception. The antinociceptive effect of neurotensin, on the other hand, is more localized.

References (28)

Cited by (41)

  • Descending facilitatory pathways from the rostroventromedial medulla mediate naloxone-precipitated withdrawal in morphine-dependent rats

    2011, Journal of Pain
    Citation Excerpt :

    There is evidence that neurons in this area mediate other homoeostatic functions besides pain.12,36,52,58,67 Additionally, the RVM may serve as a relay output for effects of the locus coeruleus.48,53,66,76 Indeed, lesions of the locus coeruleus (LC) have been shown to decrease physical signs of opioid withdrawal,33 and electrical stimulation of this nucleus or direct injection of opioid antagonists into the locus coeruleus precipitate the expression of opiate withdrawal.16,29

  • Post-ictal analgesia in genetically epilepsy-prone rats is induced by audiogenic seizures and involves cannabinoid receptors in the periaqueductal gray

    2011, Brain Research
    Citation Excerpt :

    Electrical stimulation of PAG is known to induce analgesia both in humans and animals (Mayer, 1984; Reynolds, 1969). The PAG plays a key role in the descending modulation of nociception by projecting via the rostral ventromedial medulla to spinal cord dorsal horn neurons (Liebeskind et al., 1973; Moreau and Fields, 1986; Urban and Smith, 1994). Previous studies have suggested that the PAG is also an important site for endocannabinoid-mediated analgesia (Hohmann et al., 2005; Maione et al., 2006).

  • Altered morphine-induced analgesia in neurotensin type 1 receptor null mice

    2010, Neuroscience
    Citation Excerpt :

    Our results based on a genetic approach are also in apparent contradiction with previous pharmacological findings. Indeed, administration of the NT receptor antagonists, [D-Trp11] NT or SR48692 into the RVM has been shown to potentiate the development of morphine analgesia (Urban and Smith, 1993, 1994; Smith et al., 1997). The fact that NT produces dose-dependent antinociceptive and anti-analgesic effects by acting on distinct classes of RVM neurons (ON-cells and OFF-cells) expressing different NT receptor types (NTS1 and NTS2) may explain these contrasting results (Urban and Gebhart, 1997; Urban et al., 1999; Neubert et al., 2004).

  • Descending control of nociception: Specificity, recruitment and plasticity

    2009, Brain Research Reviews
    Citation Excerpt :

    Focal application of opioids in the RVM evokes analgesia, whereas the neuropeptide cholecystokinin produces behavioral hyperalgesia (Heinricher and Morgan, 1999; Heinricher and Neubert, 2004; Kovelowski et al., 2000). Whether neurotensin microinjection in the RVM produces analgesia or hyperalgesia varies with dose, and presumably, the receptor type activated (Buhler et al, 2005; Neubert et al., 2004; Smith et al., 1997; Urban and Smith, 1994). The effects of RVM inactivation are similarly complex.

View all citing articles on Scopus
View full text